Advertisement Prisym ID Launches FDA, MHRA Compliant Web-Based Solution - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Prisym ID Launches FDA, MHRA Compliant Web-Based Solution

Prisym ID, a company that designs and delivers industry compliant RFID, labelling and barcode solutions for companies including life sciences, chemical, manufacturing and automotive, has launched a web-based solution Prisym Medica.

Prisym Medica is designed for life science companies that need to design, validate and approve labelling on a variety of products, from medical devices to pharmaceuticals and into clinical trials.

Prisym Medica offers life science companies a single solution to meet their packaging and labelling requirements. Prisym Medica has been designed to increase collaboration and lessen the expense and inefficiency of validation, by allowing all relevant parties access to the design, review and validation process online.

Prisym ID claimed that Prisym Medica is a simple to use label design and management application which allows to develop, review, validate and distribute labels aiding with compliance for the FDA and the Medicines and Healthcare products Regulatory Agency (MHRA) regulations, among others.

Additionally, it enables unique serialised codes to be automatically applied in the format necessary to meet local legislative requirements. Where appropriate, live batch information, destination information and intelligent serial numbers needed for compliance with international regulations can be passed for printing automatically.

Dave Taylor, product manager at Prisym, said: “When your product is as important as pharmaceuticals and medical devices, zero defect labelling is vital. A lack of accuracy and clarity in labelling contributes to 1 in 10 NHS patients suffering from mistakes in their treatment, while without accountability in labelling, piracy and counterfeiting, which cost the life sciences industry $38bn a year, become harder to spot.

“With Prisym Medica, we are aiming to make this accuracy and accountability as smooth, simple and straightforward as possible for life sciences companies. By allowing greater collaboration and easier access, accuracy is improved. Also the validation becomes a much faster, lower cost process, which allows vital products to be rolled out much sooner.”